274 related articles for article (PubMed ID: 18614139)
1. Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer.
Crozier JE; Leitch EF; McKee RF; Anderson JH; Horgan PG; McMillan DC
Am J Surg; 2009 Apr; 197(4):544-9. PubMed ID: 18614139
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
[TBL] [Abstract][Full Text] [Related]
3. Systemic inflammatory response predicts survival following curative resection of colorectal cancer.
McMillan DC; Canna K; McArdle CS
Br J Surg; 2003 Feb; 90(2):215-9. PubMed ID: 12555298
[TBL] [Abstract][Full Text] [Related]
4. The relationship between tumour proliferative activity, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer.
Canna K; Hilmy M; McMillan DC; Smith GW; McKee RF; McArdle CS; McNicol AM
Colorectal Dis; 2008 Sep; 10(7):663-7. PubMed ID: 18005189
[TBL] [Abstract][Full Text] [Related]
5. Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer.
Crozier JE; McKee RF; McArdle CS; Angerson WJ; Anderson JH; Horgan PG; McMillan DC
Br J Surg; 2007 Aug; 94(8):1028-32. PubMed ID: 17437250
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of outcomes of emergency and elective surgeries for complicated colonic cancer.
Biondo S; Martí-Ragué J; Kreisler E; Parés D; Martín A; Navarro M; Pareja L; Jaurrieta E
Am J Surg; 2005 Apr; 189(4):377-83. PubMed ID: 15820446
[TBL] [Abstract][Full Text] [Related]
7. The impact of blood loss, obstruction and perforation on survival in patients undergoing curative resection for colon cancer.
McArdle CS; McMillan DC; Hole DJ
Br J Surg; 2006 Apr; 93(4):483-8. PubMed ID: 16555262
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer.
Ramsey S; Lamb GW; Aitchison M; McMillan DC
BJU Int; 2008 Apr; 101(8):959-63. PubMed ID: 18190639
[TBL] [Abstract][Full Text] [Related]
9. Emergency presentation of colorectal cancer is associated with poor 5-year survival.
McArdle CS; Hole DJ
Br J Surg; 2004 May; 91(5):605-9. PubMed ID: 15122613
[TBL] [Abstract][Full Text] [Related]
10. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Kubota K
Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
[TBL] [Abstract][Full Text] [Related]
11. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
[TBL] [Abstract][Full Text] [Related]
12. The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer.
Crozier JE; McKee RF; McArdle CS; Angerson WJ; Anderson JH; Horgan PG; McMillan DC
Br J Cancer; 2006 Jun; 94(12):1833-6. PubMed ID: 16721360
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer.
Canna K; McMillan DC; McKee RF; McNicol AM; Horgan PG; McArdle CS
Br J Cancer; 2004 May; 90(9):1707-9. PubMed ID: 15150596
[TBL] [Abstract][Full Text] [Related]
14. Tumor size is associated with the systemic inflammatory response but not survival in patients with primary operable colorectal cancer.
Crozier JE; McMillan DC; McArdle CS; Angerson WJ; Anderson JH; Horgan PG; McKee RF
J Gastroenterol Hepatol; 2007 Dec; 22(12):2288-91. PubMed ID: 18031394
[TBL] [Abstract][Full Text] [Related]
15. Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer.
Ogata Y; Murakami H; Sasatomi T; Ishibashi N; Mori S; Ushijima M; Akagi Y; Shirouzu K
J Surg Oncol; 2009 Jan; 99(1):65-70. PubMed ID: 18942720
[TBL] [Abstract][Full Text] [Related]
16. The impact of spontaneous tumour perforation on outcome following colon cancer surgery.
Abdelrazeq AS; Scott N; Thorn C; Verbeke CS; Ambrose NS; Botterill ID; Jayne DG
Colorectal Dis; 2008 Oct; 10(8):775-80. PubMed ID: 18266887
[TBL] [Abstract][Full Text] [Related]
17. The relationship between tumour site, clinicopathological characteristics and cancer-specific survival in patients undergoing surgery for colorectal cancer.
Powell AG; Wallace R; McKee RF; Anderson JH; Going JJ; Edwards J; Horgan PG
Colorectal Dis; 2012 Dec; 14(12):1493-9. PubMed ID: 22507826
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer.
Richards CH; Roxburgh CS; Anderson JH; McKee RF; Foulis AK; Horgan PG; McMillan DC
Br J Surg; 2012 Feb; 99(2):287-94. PubMed ID: 22086662
[TBL] [Abstract][Full Text] [Related]
19. The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer.
Ramsey S; Lamb GW; Aitchison M; McMillan DC
Br J Cancer; 2006 Oct; 95(8):1076-80. PubMed ID: 17003778
[TBL] [Abstract][Full Text] [Related]
20. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host.
Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
Ann Surg; 2016 Feb; 263(2):326-36. PubMed ID: 25575264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
